NDC 16729-217-01 - SERTRALINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-217
- Requested NDC
- 16729-217-01
- Package NDCs from labels
- 16729-217-10, 16729-217-15, 16729-217-01, 16729-217-16, 16729-217-43
- Manufacturer
- St. Mary's Medical Park Pharmacy
- Effective date
- 2026-06-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SERTRALINE HYDROCHLORIDE - St. Mary's Medical Park Pharmacy | St. Mary's Medical Park Pharmacy | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Accord Healthcare, Inc. | Intas Pharmaceuticals Ltd | Accord Healthcare, Inc. | Intas Pharmaceuticals Ltd | 2025-12-17 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2025-09-19 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Quality Care Products, LLC | Quality Care Products, LLC | 2024-12-18 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-05-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Sertraline Hydrochloride Tablets USP | NuCare Pharmaceuticals,Inc. | 2022-07-05 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2022-06-24 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2022-03-30 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - REMEDYREPACK INC. | REMEDYREPACK INC. | 2021-09-27 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Unit Dose Services | Unit Dose Services | 2021-05-20 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2020-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Proficient Rx LP | Proficient Rx LP | 2019-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Sertraline Hydrochloride Tablets USP | NuCare Pharmaceuticals, Inc. | 2017-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-217-01 | SERTRALINE HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 19 | |
| 16729-217-10 | SERTRALINE HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 19 | |
| 16729-217-15 | SERTRALINE HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 19 | |
| 16729-217-16 | SERTRALINE HYDROCHLORIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 19 | |
| 16729-217-43 | SERTRALINE HYDROCHLORIDE | 100 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 100 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-217-15 | EA - Each | 16729-217 | eb3a47d7-6880-4830-8c75-df42367fdf09 | 1 | 2017-03-06 |
| 16729-217-16 | EA - Each | 16729-217 | cf3d11b6-fdea-49ef-94bc-bcd3a4bd91fd | 1 | 2017-03-06 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dolce and Gabbana Everlast Foundation SPF 20 12N Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 26062cd7-3817-46c7-b65f-92cd57eca5dd | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 13C Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 448a24a3-91ef-4530-828c-e77d8aae7f0b | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 02C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 09f9e59b-6f71-4d42-9b5d-275f756d985b | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 03W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3b1e4480-8409-425e-b98d-eb4dcf2471e8 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 06W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3090422e-fc18-45b8-88f2-6a9b282a7205 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 05N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f93aa5d2-90ab-4e11-874e-2ede4b25c4b6 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 04C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f055cd51-7b1d-43df-8990-8f60ba1eb91c | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 07N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | d4c76bc5-205b-45fd-8a02-4f4b17458503 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Sertraline | SERTRALINE | A-S Medication Solutions | ad69cbfe-5b42-4714-a999-77d474e0849d | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 312940 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Bryant Ranch Prepack | 50d0aef5-ecc7-49b0-964a-53f87058d22a | 2025-07-30 | Boxed warning, Warnings, Adverse reactions | 312941 UTI8907Y6X |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | B697894SGQ |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | B697894SGQ |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | B697894SGQ |
| Neutrogena Mineral Invisible Daily Defense Face Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 003123d2-9675-fdd2-e063-6294a90a0130 | 2025-07-28 | Warnings | 15FIX9V2JP |
| Neutrogena Mineral Ultra Sheer Face SPF 70 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 20e0badf-fe25-1d27-e063-6294a90a7cfe | 2025-07-28 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 01N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 2ccf4e45-4cec-417d-9f4c-28f376025f1d | 2025-07-25 | Warnings | 15FIX9V2JP |
| Sunscreen | TITANIUM DIOXIDE 6.8% | Baxter of California, LLC | 146030bc-2bf4-25ea-e063-6294a90a4613 | 2025-07-24 | Warnings | 15FIX9V2JP |
| La Defense Broad Spectrum SPF 30 Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | Luzern Laboratories, Inc | 3f00befa-415d-415d-89e1-6ba8770ba51e | 2025-07-21 | Warnings | 15FIX9V2JP |
| SERTRALINE | SERTRALINE | Aphena Pharma Solutions - Tennessee, LLC | 1548faf9-8625-f871-e063-6394a90a931f | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | 312941 UTI8907Y6X |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | c277f1d8-2ee0-4111-adb6-38998f77dede | 2025-07-18 | Warnings | L11K75P92J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.